Live Yum Brands Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Moderna, Inc.

Get SEC filing alerts via email and in your feed for Moderna, Inc.

MRNA

Moderna, Inc.

About Moderna, Inc.

Moderna, Inc. is a biotechnology company specializing in mRNA technology to develop vaccines and therapeutics across infectious diseases, oncology, and rare conditions. Its core products include COVID-19 and RSV vaccines, with a pipeline of vaccines targeting influenza, herpes, HIV, and other viruses. The company leverages its platform for rapid development, manufacturing efficiency, and broad applicability, serving global markets with a focus on innovative, gene-based medicines.
This description was generated via AI from an annual report. Updated 10 months ago.

Latest SEC Filings from Moderna, Inc.

1
1
Moderna, Inc. Moderna Reports $389 Million Revenue in Q1 2026, Despite $1.343 Billion Net Loss

Via official filing (AI summary) | 3 months ago | 0 comments

2
1
Moderna, Inc. Diamond or dud? - MRNA - March 2026

Posted by AssetRoom | 5 months ago | 1 comments

3
1
Moderna, Inc. Moderna Reports $1.9 Billion Revenue and $2.8 Billion Net Loss for Fiscal Year 2025

Via official filing (AI summary) | 5 months ago | 0 comments

4
1
Moderna, Inc. Moderna Reports 45% Revenue Decline in Q3 2025, Net Loss of $200 Million

Via official filing (AI summary) | 9 months ago | 0 comments

5
1
Moderna, Inc. Moderna Reports 41% Revenue Decline in Q2 2025, Net Loss Improves

Via official filing (AI summary) | 12 months ago | 0 comments

6
1
Moderna, Inc. Moderna Reports $971 Million Net Loss in Q1 2025, Revenue Declines 35%

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
Moderna, Inc. Moderna Reports Mixed Q3 Results, Net Income Turnaround, and FDA Approval for RSV Vaccine

Via official filing (AI summary) | over 1 year ago | 0 comments